ARCHIVES

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

This article is from The Cancer Letter archive.

Vol. 26 No. 6 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

Substance From Sea Squirts In Phase II For Breast Cancer

November 29, 2002

Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says

February 19, 1993

Neutron Clinical Trials Contract Concept Approved

June 22, 1984

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992

ACS Ask Stronger Federal Action Against Cigarettes

November 23, 1979

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012